437 related articles for article (PubMed ID: 21726833)
1. CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.
Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
Cell Stem Cell; 2011 Jul; 9(1):50-63. PubMed ID: 21726833
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
3. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Yang C; Cai WC; Dong ZT; Guo JW; Zhao YJ; Sui CJ; Yang JM
Gene; 2019 Mar; 687():73-81. PubMed ID: 30391438
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of ZFX confers self-renewal and chemoresistance properties in hepatocellular carcinoma.
Lai KP; Chen J; He M; Ching AK; Lau C; Lai PB; To KF; Wong N
Int J Cancer; 2014 Oct; 135(8):1790-9. PubMed ID: 24585547
[TBL] [Abstract][Full Text] [Related]
5. NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma.
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2020 Apr; 476():48-56. PubMed ID: 32061952
[TBL] [Abstract][Full Text] [Related]
6. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
[TBL] [Abstract][Full Text] [Related]
7. Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma.
Luo Y; Yang Z; Su L; Shan J; Xu H; Xu Y; Liu L; Zhu W; Chen X; Liu C; Chen J; Yao C; Cheng F; Zhang C; Ma Q; Shen J; Qian C
Cancer Lett; 2016 Jun; 375(2):390-399. PubMed ID: 27000993
[TBL] [Abstract][Full Text] [Related]
8. Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24.
Liu AY; Cai Y; Mao Y; Lin Y; Zheng H; Wu T; Huang Y; Fang X; Lin S; Feng Q; Huang Z; Yang T; Luo Q; Ouyang G
Carcinogenesis; 2014 Mar; 35(3):537-45. PubMed ID: 24193512
[TBL] [Abstract][Full Text] [Related]
9. Tex10 is upregulated and promotes cancer stem cell properties and chemoresistance in hepatocellular carcinoma.
Xiang X; Deng L; Xiong R; Xiao D; Chen Z; Yang F; Liu K; Feng G
Cell Cycle; 2018; 17(11):1310-1318. PubMed ID: 30045663
[TBL] [Abstract][Full Text] [Related]
10. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts promote the stemness of CD24
Li Y; Wang R; Xiong S; Wang X; Zhao Z; Bai S; Wang Y; Zhao Y; Cheng B
J Mol Med (Berl); 2019 Feb; 97(2):243-255. PubMed ID: 30564864
[TBL] [Abstract][Full Text] [Related]
12. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
13. Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma.
Lee TK; Cheung VC; Ng IO
Cancer Lett; 2013 Sep; 338(1):101-9. PubMed ID: 22579789
[TBL] [Abstract][Full Text] [Related]
14. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro].
Peng L; Li FX; Shao WF; Xiong JB
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1421-6. PubMed ID: 24144739
[TBL] [Abstract][Full Text] [Related]
15. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
[TBL] [Abstract][Full Text] [Related]
16. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
[TBL] [Abstract][Full Text] [Related]
17. LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression.
Chen ZZ; Huang L; Wu YH; Zhai WJ; Zhu PP; Gao YF
Nat Commun; 2016 Aug; 7():12598. PubMed ID: 27553854
[TBL] [Abstract][Full Text] [Related]
18. Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.
Lee TK; Castilho A; Cheung VC; Tang KH; Ma S; Ng IO
Hepatology; 2011 Jan; 53(1):160-70. PubMed ID: 20979057
[TBL] [Abstract][Full Text] [Related]
19. Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1-Stat3.
Wu CX; Xu A; Zhang CC; Olson P; Chen L; Lee TK; Cheung TT; Lo CM; Wang XQ
Mol Cancer Ther; 2017 Aug; 16(8):1531-1543. PubMed ID: 28522590
[TBL] [Abstract][Full Text] [Related]
20. Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma.
Zhang Q; Lu C; Fang T; Wang Y; Hu W; Qiao J; Liu B; Liu J; Chen N; Li M; Zhu R
Oncotarget; 2015 Feb; 6(6):3669-79. PubMed ID: 25668819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
